Propanc Biopharma, Inc.
PPCBNasdaqCIK 1517681HealthcareFiscal year ends Jun 30
Reports and events: 233 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2015-11-1615:10 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001144204-15-065865 |
| 2015-11-0317:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001144204-15-062542 |
| 2015-09-3017:13 ET | 10-K | Annual reportPeriod 2015-06-30 | 0001144204-15-057458 |
| 2015-09-2913:40 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001144204-15-057068 |
| 2015-07-1508:03 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001144204-15-042591 |
| 2015-06-1812:52 ET | 8-K | 8.01 Other events | 0001144204-15-037856 |
| 2015-05-1515:48 ET | 10-Q | Quarterly reportPeriod 2015-03-31 | 0001144204-15-031499 |
| 2015-04-1316:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001144204-15-022487 |
| 2015-02-1709:56 ET | 10-Q | Quarterly reportPeriod 2014-12-31 | 0001144204-15-009533 |
| 2015-01-0219:52 ET | SC 13D | Ownership report, active investor | 0001445866-14-001660 |
| 2014-12-1607:21 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001144204-14-074117 |
| 2014-11-1917:18 ET | 10-Q | Quarterly reportPeriod 2014-09-30 | 0001144204-14-069836 |
| 2014-10-1416:28 ET | 10-K | Annual reportPeriod 2014-06-30 | 0001144204-14-060984 |
| 2014-09-2217:28 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001144204-14-057175 |
| 2014-05-2009:02 ET | 10-Q | Quarterly reportPeriod 2014-03-31 | 0001354488-14-002818 |
| 2014-02-1411:34 ET | 10-Q | Quarterly reportPeriod 2013-12-31 | 0001354488-14-000725 |
| 2013-11-1415:04 ET | 10-Q | Quarterly reportPeriod 2013-11-13 | 0001354488-13-006349 |
| 2013-10-1515:19 ET | 10-K | Annual reportPeriod 2013-06-30 | 0001354488-13-005698 |
| 2013-05-2014:22 ET | 10-Q | Quarterly reportPeriod 2013-03-31 | 0001354488-13-003018 |
| 2013-02-2017:34 ET | 10-Q | Quarterly reportPeriod 2012-12-31 | 0001354488-13-000756 |
| 2012-11-1916:14 ET | 10-Q | Quarterly reportPeriod 2012-09-30 | 0001354488-12-006039 |
| 2012-10-1515:12 ET | 10-K | Annual reportPeriod 2012-10-11 | 0001354488-12-005291 |
| 2012-08-1316:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001354488-12-004064 |
| 2012-06-2709:44 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001354488-12-003394 |
| 2012-05-2111:43 ET | 10-Q | Quarterly reportPeriod 2012-03-31 | 0001354488-12-002768 |
| 2012-03-0717:28 ET | 10-Q/A | Quarterly report, amendedPeriod 2011-12-31 | 0001354488-12-001037 |
| 2012-02-2108:38 ET | 10-Q | Quarterly reportPeriod 2011-12-31 | 0001354488-12-000758 |
| 2011-12-0818:42 ET | S-1/A | Registration statement, amended | 0001354488-11-004896 |
| 2011-11-1410:30 ET | S-1/A | Registration statement, amended | 0001354488-11-004277 |
| 2011-10-2716:56 ET | S-1/A | Registration statement, amended | 0001354488-11-003958 |
| 2011-09-3016:38 ET | S-1/A | Registration statement, amended | 0001354488-11-003637 |
| 2011-08-1816:51 ET | S-1/A | Registration statement, amended | 0001354488-11-002979 |
| 2011-06-2315:29 ET | S-1 | Registration statement | 0001354488-11-001953 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.